Cas:1160248-14-5 benzyl 2,4-dichloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate manufacturer & supplier

We serve Chemical Name:benzyl 2,4-dichloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate CAS:1160248-14-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

benzyl 2,4-dichloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate

Chemical Name:benzyl 2,4-dichloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate
CAS.NO:1160248-14-5
Synonyms:benzyl 2,4-dichloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate
Molecular Formula:C15H13Cl2N3O2
Molecular Weight:338.18900
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:55.32000
Exact Mass:337.03800
LogP:3.41620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like benzyl 2,4-dichloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,benzyl 2,4-dichloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,benzyl 2,4-dichloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate Use and application,benzyl 2,4-dichloro-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate technical grade,usp/ep/jp grade.


Related News: With the chemical industry being one of the most polluting, global efforts are heavily focused on developing a more sustainable and greener footprint. 1-(4-chlorophenyl)pyrrolidin-2-one manufacturers Altogether, the IPO added $550 million to the family’s collective fortune, which now stands at an estimated $4.8 billion. methyl 4-bromo-3-(trifluoromethyl)benzoate suppliers With the closing of AstraZeneca’s mega $39 billion buyout of Alexion Pharmaceuticals this week, the U.K. pharma has officially picked up Soliris and its successor, Ultomiris. (3-(1H-Imidazol-1-yl)phenyl)methanamine vendor & factory.